Dr. Anna-Maria Hoffmann-Vold serves as the Head of the Inflammatory and Fibrotic Rheumatic Disease Research Area at Oslo University Hospital. She is also the chair of the comorbidity research in rheumatic diseases at the REMEDY center in Oslo. As a senior consultant, she specializes in the care of patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) associated with various rheumatic diseases. She chairs the EULAR study group focusing on lung involvement in rheumatic and musculoskeletal diseases.

Her primary expertise and interests lie in clinical and translational research on SSc and other CTDs, particularly concerning ILD and pulmonary arterial hypertension. She is committed to developing management recommendations and conducting clinical trials in these areas.